
Diamond Breakthrough: Off-the-Shelf Immunotherapy for Kidney Cancer
MEDICAL XPRESS
UCLA scientists have engineered AlloCAR70-NKT—an “off-the-shelf” immune cell therapy, ready-to-use, that attacks kidney tumors directly, reprograms protective environments, and avoids need for custom patient cells. A hopeful leap for late-stage cancer treatment.